Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus

Search Close Search

Print

2021 Press Releases

-Archives-

Video capsule endoscopy safe, effective alternative for diagnosing GI bleeding during COVID-19

Video capsule endoscopy safe, effective alternative for diagnosing GI bleeding during COVID-19

David Cave, MD, PhD, and colleagues at UMass Medical School found that using video capsule endoscopy as a first procedure for the detection of the source of acute gastrointestinal bleeding could be a safe and effective alternative to the traditional method.

M2D2 $200K Challenge names biomedical innovation contest winners

M2D2 $200K Challenge names biomedical innovation contest winners

UMass Medical School and UMass Lowell announced the winners of the 2021 Massachusetts Medical Device Development Center $200K Challenge. Acoustica Bio, a startup aiming to transform how patients receive intravenous medications, is the top winner.

UMMS establishes gene therapy collaborative research agreement with Pfizer

UMMS establishes gene therapy collaborative research agreement with Pfizer

UMass Medical School has entered into a three-year, collaborative research agreement with Pfizer to evaluate determinants that influence the manufacturing quality and yield of viral vectors used in gene therapy. The research at UMMS is being performed under the direction of Guangping Gao, PhD, and Dan Wang, PhD.

Erik Sontheimer co-leading efforts to develop gene editing toolkit by NIH Somatic Cell Genome Editing Consortium

Erik Sontheimer co-leading efforts to develop gene editing toolkit by NIH Somatic Cell Genome Editing Consortium

Six UMass Medical School scientists are among the members of the National Institutes of Health’s Somatic Cell Genome Editing Consortium to publish a paper in Nature outlining the program’s goals.

UMass Medical School helps lead NIH RADx to accelerate new COVID test technologies

UMass Medical School helps lead NIH RADx to accelerate new COVID test technologies

The national effort to bring convenient, affordable and rapid testing technology for SARS-CoV-2 infection to market is moving full speed ahead. The $1.5 billion effort was launched a year ago, with UMass Medical School playing a major role in coordinating the push for fast, accessible COVID-19 testing.

High school senior Neil Kale wins 15th annual Central Massachusetts Brain Bee

High school senior Neil Kale wins 15th annual Central Massachusetts Brain Bee

The annual event, designed to stimulate high school students’ interest in neuroscience, was hosted by the Departments of Psychiatry and Neurology and the NeuroNexus Institute at UMass Medical School via Zoom on Saturday, March 20.

New study of oral therapy candidate indicates positive results for patients with mild-to-moderate COVID-19

New study of oral therapy candidate indicates positive results for patients with mild-to-moderate COVID-19

New research by Kaleido Biosciences, Inc., and UMass Medical School’s John P. Haran, MD, PhD, and Beth McCormick, PhD, shows that the company’s microbiome metabolic therapy candidate produced positive results in patients with mild-to-moderate COVID-19.

Drive-in Match Day a unique occasion for soon-to-be UMass Medical School grads

Drive-in Match Day a unique occasion for soon-to-be UMass Medical School grads

The School of Medicine hosted its annual Match Day celebration with a socially distanced drive-in event at the South Street campus on Friday, March 19. This year’s class is the largest ever, with 168 graduating students.

Video: Preventive shot for Lyme disease, now in clinical trial, explained

Video: Preventive shot for Lyme disease, now in clinical trial, explained

A pre-exposure prophylaxis to prevent Lyme disease, developed at MassBiologics of UMass Medical School and now being tested in a year-long human clinical trial, could be ready for licensure in about two and a half years, according to Mark Klempner, MD.

Infectious disease expert Robert Finberg: COVID reinfections rare, but caution still urged

Infectious disease expert Robert Finberg: COVID reinfections rare, but caution still urged

Reinfection with the SARS-CoV-2 virus has occurred among people who previously were sick with COVID-19, but the number of reported cases is still very small. Robert Finberg, MD, explains why researchers are tracking those cases.

Showing 1-10 of 33 items
of 4